In this editorial, Harrington and coauthors introduce the updated guidelines for statistical reporting in the New England Journal of Medicine, which can be accessed at https://www.nejm.org/author-center/new-manuscripts.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Basic Science
June 27, 2019
An interesting small British-led randomized controlled trial on modern imaging of coronary atheroma.
April 30, 2019
Aortic endografting leads to aortic stiffening. In this experimental animal study, Yamashita and colleagues evaluated the effect that thoracic endografting had on cardiac afterload, function, and remodeling.
March 15, 2019
Very useful open access review, especially the simple figure on page 959.
In Global News: Heart Cells in Space, July Surgery Outcomes, and Monitoring for Transplant Rejection
February 1, 2019
Patient Care and General Interest
Former Indian Prime Minister Manmohan Singh chimes in to the #10YearChallenge with a focus on his heart surgery.
November 9, 2018
Interesting small randomized controlled trial that will definitely be widely discussed.
August 30, 2018
In this interview, Vaibhav Gupta and Shaf Keshavjee discuss ex vivo lung perfusion and being a surgeon-scientist.
August 29, 2018
Hickey and colleagues discuss the assumptions that underlie regression models, and they detail approaches to identifying deviations from these assumptions. They illustrate several points using linear regression as the basis but also discuss logistic regression and Cox regression models.
August 17, 2018
A useful if somewhat belated account of the Papworth experience in lung donation after circulatory determined death (DCD) until 2015. There are no data on heart and lung transplants in that 6-year period. No DCD recipient required extracorporeal membrane oxygenation, and DCD single lung recipients did badly.
August 13, 2018
The 5-year survival rate in patients after curative surgery for N0 nonsmall cell lung cancer (NSCLC) is reduced by recurrence and metastasis, and there is evidence that the epithelial–mesenchymal transition in cancer cells is associated with metastasis.